Strategic partnerships GATC Biotech has a history of collaboration with prominent research institutes and industry players (Fraunhofer ILT, National University of Pusan, Gene In Corporation) which signals openness to joint projects and outsourcing opportunities. Leverage these networks to pitch co-development, contract sequencing, and bioinformatics service expansions.

Acquisition-backed scale As a former subsidiary of Eurofins with a revenue under one million, GATC Biotech presents a target for incremental service expansion, tiered pricing for larger genome projects, and cross-selling of Eurofins’ analytics capabilities to its clients seeking end-to-end solutions.

Full‑service sequencing Position GATC Biotech as a gateway for customers needing end-to-end sequencing and bioinformatics—from sample processing to genome projects—offering bundled services, project management, and scalable capacity for academic and industrial customers.

Growing capabilities Historical product launches such as GATCLIQUID and isoform characterization indicate ongoing innovation. This presents opportunities to upsell advanced sequencing technologies and specialized analyses to existing customers pursuing cutting-edge genomics workflows.

SME target potential With a relatively small employee base and niche expertise, there is a clear path to targeting mid-market biotech firms, CROs, and academic labs needing flexible, high-quality sequencing and bioinformatics services on a scalable basis.